STOK - Rasio utang marang kapitalisasi buku Stoke

Tandha merek Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics (STOK) lacks stable revenue streams, as its financial position at the 0.01 level depends on external funding. The company is mitigating risks by developing drugs to combat vision pathologies and epilepsy. This daily price chart reflects the price action, highlighting the scaling potential of RNA therapy, which, upon regulatory approval, could secure global leadership and high margins for the firm.

Utang marang modal buku: Stoke Therapeutics (STOK) kanggo 04.07.2022 - 27.10.2026

Rincian metrik lan analitis perusahaan Stoke Therapeutics Inc (STOK)

- rega lan prakiraan konsensus rega:
Rega saham Stoke Therapeutics|STOK - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Stoke Corp|STOK - Rega Tumbas Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi saben Saham Stoke Therapeutics|STOK - Total Aset Bersih|Rasio Nilai Pasar marang Nilai Buku stoketherapeutics.com|STOK - Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Stoke Therapeutics|STOK - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Stoke|STOK - Utang kumulatif perusahaan|Utang marang nilai buku Stoke Corp
Analisis kabeh metrik perusahaan:STOK, Stoke Therapeutics
Sampel barang Stoke Therapeutics Inc

This indicator measures the share of total liabilities within the balance sheet capital structure, allowing for an assessment of financial leverage and the risk of over-indebtedness. By analyzing the ratio of total debt to book capitalization, an investor can confirm the stability of Stoke Therapeutics (STOK), whose management effectively funds gene therapy development by attracting investment capital while minimizing reliance on borrowed funds.

Pesaing Stoke Therapeutics (STOK)

Utang-utang marang kapitalisasi buku TEM (Tempus AI Inc)|qiagen.com - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IONS (Ionis)|Repligen Corp (RGEN) - Utang-utang marang aset resik|RNA - Utang marang nilai buku|CRSP (CRISPR) - Utang marang modal buku|Rasio utang marang kapitalisasi buku WGS (GeneDx Holdings Corp.)|Utang-utang marang nilai buku RARE|Rasio utang marang kapitalisasi buku BEAM|Utang-utang marang kapitalisasi buku Sarepta Therapeutics (SRPT)|TWST: Utang-utang marang kapitalisasi buku|TXG - Utang-utang marang nilai buku|Utang marang nilai buku Intellia Therapeutics (NTLA)|biolifesolutions.com (BLFS) - Rasio utang marang aset resik|WVE - Utang marang nilai buku|Maze Therapeutics, Inc. (MAZE) - Utang marang modal buku|SION - Utang-utang marang kapitalisasi buku|Rasio utang marang aset resik Prime Medicine Bio|Taysha Gene Therapies - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku QURE (uniqure.com)|Rasio utang marang kapitalisasi buku MeiraGTx|Rasio utang marang aset resik REGENXBIO Inc RGNX|Solid Bio - Utang-utang marang kapitalisasi buku|OCGN: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Pacific Biosciences (PACB)|benitec.com (BNTC) - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku DSGN (Design Therapeutics, Inc.)|Utang-utang marang nilai buku Rocket Pharma (RCKT)|Utang marang nilai buku FDMT|Utang-utang marang kapitalisasi buku lexeotx.com LXEO|Utang marang nilai buku Korro Bio (KRRO)|Utang marang modal buku editasmedicine.com EDIT|Utang-utang marang kapitalisasi buku SLN (Silence Therapeutics plc)|PRQR - Utang-utang marang aset resik|CDXS (codexis.com) - Utang-utang marang kapitalisasi buku|SGMO (Sangamo BioSciences) - Utang marang nilai buku|NAUT: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik MGX|DTIL (Precision BioSciences, Inc.) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik generationbio.com GBIO|Utang marang nilai buku Boundless Bio, Inc (BOLD)|Exicure Inc. - Utang marang modal buku|IMNN (Celsion Corporation) - Rasio utang marang kapitalisasi buku|PHIO: Utang-utang marang nilai buku|MBIO: Rasio utang marang kapitalisasi buku|TransCode Therapeutics, Inc. (RNAZ) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Bionano Genomics Inc. (BNGO)|Rasio utang marang nilai buku APDN|Rasio utang marang kapitalisasi buku bluebird bio, Inc. BLUE|Rasio utang marang nilai buku immunoprecise.com (IPA)|Utang-utang marang kapitalisasi buku OMGA (Omega Therapeutics, Inc.)|Singular Genomics Systems, Inc. - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku RGLS (Regulus Therapeutics Inc)|Syros Pharmaceuticals, Inc (SYRS) - Utang-utang marang aset resik|TBIO - Utang marang nilai buku|TCON (traconpharma.com) - Utang marang modal buku|Rasio utang marang kapitalisasi buku UBX (Unity Biotechnology, Inc.)